BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Carfilzomib: Expanded access program started

Onyx and the Multiple Myeloma Research Foundation (MMRF) began the open-label, U.S. C-MAP expanded access program to evaluate 20 and 27 mg/m 2 IV carfilzomib in 28-day cycles in patients with relapsed and refractory...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >